Posts Tagged SpaceX

SpaceX's $100 billion Louisiana spaceport will not be auditable before 2027 and will not produce anything measurable before 2029. Who Counts the Capex asked what happens to a number like that: announced capex commits nothing and leaves no line item if it never arrives. This piece asks what happens to the holders, because the SpaceX share register is turning over on a published schedule long before the announcement can be checked.

SpaceX reported $18.37 billion in quarterly capex. Two days later, it announced the first phase of a semiconductor campus that could eventually involve far more spending. The difference between those numbers is more important than the market reaction. Committed spending gets measured. Announced spending keeps its optionality. That matters as AI infrastructure spending accelerates toward extraordinary levels and a growing share is financed with debt. It matters even more as frontier AI companies prepare to enter public markets. The deeper question is whether quarterly reporting is built to price research programs whose costs arrive now but whose payoff may be decades away. SpaceX offers a useful case study in what happens when long-duration technological bets meet the short-duration accountability of public markets.

SpaceX’s first major post-IPO lock-up release offered a useful test of how these events actually behave. Ahead of the 6 August release, 3 claims were on the table: the conditional 455.8 million-share tranche would remain locked, eligibility to sell would not necessarily mean actual selling, and an expanding free float could create additional passive demand alongside new supply. The conditional tranche did fail its price test, leaving 911.5 million shares eligible for release. SpaceX’s free float then jumped from roughly 4.9% to 11.8%. But instead of collapsing under the new supply, the stock rose 6.1% on release day and closed at $133.11 the following session, up another 15.83%. Two of the 3 predictions held. The third was never actually tested. The bigger lesson is that a lock-up expiry is more complicated than “more shares = more selling.” Eligibility, actual selling, float mechanics, and market demand are separate forces, and the SpaceX release showed why that distinction matters.

Since its June 12 IPO, SpaceX has completed a full round trip, pricing at $135, surging above $225 within days, and now trading below its offer price. The debate is no longer about what SpaceX was worth as a private company. The market is trying to determine what kind of public company it is becoming. One increasingly useful way to think about SpaceX is as an emerging hyperscaler. It may not follow the path of Amazon, Microsoft, or Google, but its combination of launch infrastructure, Starlink, and AI compute is creating a business model that looks increasingly familiar, while pointing toward a very different destination.

Earlier this week, the argument was that SpaceX's Nasdaq-100 inclusion failed to lift the stock because the market had already priced it in. The rule change was public, the timing was known, and the passive buying was predictable. The obvious follow-up question is whether the same logic applies to upcoming lock-up expirations. If everyone knows the dates and the number of shares involved, shouldn't those already be priced in too? The answer highlights an important distinction in market structure: must versus may. Index funds must buy. Insiders may sell. That difference explains why some highly anticipated events disappear into the price, while others continue to move markets.

SpaceX entered the Nasdaq-100 just 15 trading days after its IPO, triggering an estimated $4 billion in forced buying from index funds. The stock still fell about 7% and closed below its debut price. That was not a market failure. It was a reminder that widely anticipated demand is often priced in before the actual buying begins. When every participant can see the same trade coming, the event itself may become the exit rather than the catalyst. The real lesson is not that index inclusion failed. It is that mechanical demand does not guarantee upside when the market has already traded ahead of it.

Tokenized IPOs moved from theory to reality in 2026. Securitize’s NYSE listing showed how an issuer-sponsored token can represent the same underlying share on-chain, while new models from Backpack, Superstate, and Ondo are beginning to move IPO allocation and debut-day access onto Solana. With tokenized equity volume reaching roughly $3.86 billion in June, the infrastructure is taking shape. The next question is whether tokenization changes only how shares settle, or who gets access in the first place.

The market interpreted the reported OpenAI delay primarily through a macro lens, suggesting that the mega-IPO wave was slowing due to weakening public demand. However, this perspective may not be the most insightful. A more effective lens to consider is structure. If the reports are accurate, the inquiry posed to OpenAI was not about whether to go public at all, but rather whether to list sooner at a valuation below $1 trillion or to wait for market conditions that would support its desired valuation. Sam Altman reportedly viewed a reduction to that figure as unacceptable. This distinction is significant because it separates two concepts that are often conflated: investor appetite and entry point. A headline stating "OpenAI delays IPO" might imply a decrease in demand, but it could actually indicate a commitment to price discipline. The public market may still be interested in the company, but it may not be willing to meet the private-market valuation being proposed, which conveys a very different message.

Two weeks ago, the market's loudest fear was supply. SpaceX had just executed the largest IPO in history, raising approximately $75 billion at $135 a share, valuing the company near $1.77 trillion. Following closely were OpenAI and Anthropic, both anticipated to follow suit. The bearish narrative spread quickly: a wave of mega-listings could extract a trillion dollars of value from the broader market as investors sold existing holdings to fund new shares. However, this week, the anticipated wave began to slow down. OpenAI is reportedly considering delaying its IPO until 2027. Advisers have presented the company with a choice: list sooner at a valuation below $1 trillion or wait for more favorable conditions that align with its desired valuation. Sam Altman reportedly shows little interest in accepting a discount. The news caused a significant drop for SoftBank, one of OpenAI’s largest outside backers. This caution signals a shift in focus. The key question is no longer whether demand exists for these listings, but whether that demand will support the valuations seen in the private market.

T-OpenAI represents a tokenized loan participation right, offering economic exposure tied to the valuation of OpenAI private shares. It is important to note that T-OpenAI is not equity; it does not grant the holder shareholder status, ownership, voting rights, or dividends. The overarching goal is straightforward: to move the access point to this type of investment earlier. This financial instrument is structured through a Cayman Islands SPC and issued by a dedicated subsidiary of Tessera Works Foundation. It operates entirely on the Solana blockchain, ensuring liquidity, transferability, and composability from day one. The unique structure of T-OpenAI enables private-market exposure, which has traditionally been limited to institutional investors, to be brought on-chain. This approach provides clarity regarding the nature of the asset and its limitations.